Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
New York Attorney General Letitia James on Friday released what she described as “shocking and disturbing” footage from ...
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...
By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...
T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...
Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...
Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...
The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...
The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback